These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17062942)

  • 41. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gelatinases and their tissue inhibitors during human ovulation: increased expression of tissue inhibitor of matrix metalloproteinase-1.
    Lind AK; Dahm-Kähler P; Weijdegård B; Sundfeldt And K; Brännström M
    Mol Hum Reprod; 2006 Dec; 12(12):725-36. PubMed ID: 17071711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
    Anand SP; Selvaraj P
    Clin Immunol; 2009 Oct; 133(1):126-31. PubMed ID: 19615945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The expression of calpain II in rat lens epithelial cells of hydrogen peroxide-induced cataract].
    Xu W; Yao K; Wang K; Shentu X; Qiu P
    Zhonghua Yan Ke Za Zhi; 2002 May; 38(5):282-5. PubMed ID: 12133374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteopontin: a component of matrix in capsular opacification and subcapsular cataract.
    Saika S; Miyamoto T; Ishida I; Ohnishi Y; Ooshima A
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1622-8. PubMed ID: 12657601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and effect of basic fibroblast growth factor on human cataract lens epithelial cells.
    Shentu X; Yao K; Sun C; Xu W; Wu R
    Chin Med J (Engl); 2002 Feb; 115(2):268-71. PubMed ID: 11940346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matrix metalloproteinase-26 is present more frequently in squamous cell carcinomas of immunosuppressed compared with immunocompetent patients.
    Kuivanen T; Jeskanen L; Kyllönen L; Isaka K; Saarialho-Kere U
    J Cutan Pathol; 2009 Sep; 36(9):929-36. PubMed ID: 19674198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of SiO2 on the expression of MMP-9 and TIMP-1 in human alveolar macrophages in vitro].
    Ma XB; Li XL; Sun SX; Yang F
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Jun; 23(3):203-5. PubMed ID: 16124900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents.
    Głowińska-Olszewska B; Urban M
    Metabolism; 2007 Jun; 56(6):799-805. PubMed ID: 17512313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
    Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
    Belo VA; Souza-Costa DC; Lana CM; Caputo FL; Marcaccini AM; Gerlach RF; Bastos MG; Tanus-Santos JE
    Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.
    Fiotti N; Altamura N; Orlando C; Simi L; Reimers B; Pascotto P; Zingone B; Pascotto A; Serio M; Guarnieri G; Giansante C
    Int J Cardiol; 2008 Jul; 127(3):350-7. PubMed ID: 17706812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Levels of matrix metalloproteinase-9 and its inhibitor in guinea pig asthma model following ovalbumin challenge.
    Tang LF; Du LZ; Zou CC; Gu WZ
    Fetal Pediatr Pathol; 2005; 24(2):81-7. PubMed ID: 16243752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
    Wei JC; Lee HS; Chen WC; Shiu LJ; Yang SF; Wong RH
    Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Assay of matrix metalloproteinase levels and their endogenous inhibitors in patients with laryngeal carcinoma].
    Klisho EV; Savenkova OV; Kondakova IV; Perel'muter VM; Choĭnzonov EL; Shishkin DA
    Vopr Onkol; 2007; 53(1):26-31. PubMed ID: 17649730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
    Wilton E; Bland M; Thompson M; Jahangiri M
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of alphasmooth muscle actin in lens epithelia from human donors and cataract patients.
    Rungger-Brändle E; Conti A; Leuenberger PM; Rungger D
    Exp Eye Res; 2005 Nov; 81(5):539-50. PubMed ID: 15935344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.
    Määtta M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Santala M
    Anticancer Res; 2007; 27(4C):2753-8. PubMed ID: 17695443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves.
    Togashi M; Tamura K; Nitta T; Ishizaki M; Sugisaki Y; Fukuda Y
    Pathol Int; 2007 May; 57(5):251-9. PubMed ID: 17493172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.